Multi-functional electrochemical system is designed specifically to maximise the impact of EC technology for the pharmaceutical researcher
ESA has announced the launch of the DiscovArray multi-functional electrochemical (EC) system designed specifically to maximise the impact of EC technology for the pharmaceutical researcher.
The DiscovArray was developed to provide the optimal platform to study the important chemical and pharmacological properties of potential drug candidates.
Offering the full specificity and sensitivity benefits of EC detection the DiscovArray easily integrates with both isocratic and gradient HPLC or LC/MS systems to provide a unique platform capable of performing all redox applications in a single configuration.
For many years, EC systems merely measured the flow of electrons generated from a reaction to measure a given analyte.
Recently however researchers have begun to understand and exploit the ability of EC technology to perform oxidation/reduction reactions to mimic and study many important biological processes.
It is well known that many key biological and pharmacological properties of copounds have their basis in redox chemistry.
Bringing together a powerful combination of proven technology, important application developments, and optimised performance the DiscovArray enables researchers with a single system to use redox chemistry to better understand the biology of drug metabolism, metabolic profiling, compound stability, synthesis and toxicology studies.
With the DiscovArray, scientists can quickly switch between applications with minimal time and effort.
Utilising standard data management tools the system is easy to operate and control.
The DiscovArray represents the latest advance in ESA's drug discovery initiative.
